Dravet syndrome is a rare, severe form of epilepsy that begins in the first year of life, typically caused by a de novo mutation in the SCN1A gene and estimated to affect roughly 1 in 15,000 to 1 in 40,000 births. It usually starts with prolonged seizures triggered by fever, then progresses to multiple seizure types alongside developmental delay, impaired movement and coordination, and lifelong care needs. For decades, the condition has been framed almost entirely around seizure control — but a cluster of 2026 studies suggests that two largely unaddressed burdens, developmental and behavioral comorbidities that generic tools fail to capture, and a pervasive silence around the risk of sudden death, may weigh on families just as heavily as the seizures themselves.
The Conversation Many Families Never Get
Sudden Unexpected Death in Epilepsy (SUDEP) is the leading cause of epilepsy-related mortality, and people with Dravet syndrome face one of the highest SUDEP risks of any epilepsy syndrome. Yet a 2026 international survey of 615 caregivers of people with developmental and epileptic encephalopathies across 34 countries, published in Epilepsia Open, found that 55% had never received SUDEP information from a healthcare professional, and among those who did, the median delay between seizure onset and disclosure was nearly six years. SUDEP risk was linked to substantial anxiety, sleep disturbance, and heightened fear during fevers or periods of more frequent seizures, and single caregivers reported significantly higher family-impact scores. Despite this widespread emotional toll, only 8.8% of caregivers had received psychological support, and 74.1% felt the preventive measures available to them were inadequate.
If You're Living With SUDEP Fear
- You deserve this information, even if no one offers it first. The survey found most caregivers were never told about SUDEP by a doctor. If you haven't had this conversation, it's reasonable to ask your child's neurology team directly rather than wait for it to come up.
- Your fear during fevers or bad seizure stretches is not an overreaction. Caregivers in the study reported real spikes in anxiety during exactly these moments. That response reflects an accurate read of genuine risk, not an exaggerated one.
- Ask what preventive measures actually exist for your situation. Options like seizure-detection devices, safety monitoring, and nighttime supervision protocols exist, though most caregivers in the study felt current options were still insufficient — it's still worth learning what's realistically available to you.
- Psychological support for this specific fear is rare, but worth pursuing. Fewer than 1 in 10 caregivers in the survey had received any psychological support for SUDEP-related distress, which likely reflects a gap in care systems rather than a sign that support isn't needed or available anywhere.
- Connecting with other Dravet caregivers can ease the isolation. Dravet-specific caregiver communities and foundations often hold both practical knowledge about risk-reduction and a shared understanding of this fear that's hard to find elsewhere.
Comorbidities That Standard Tools Miss
A 2026 study in Epilepsia introduced the D-DAND scale, the first caregiver-administered tool designed specifically to capture the developmental and behavioral comorbidities of Dravet syndrome beyond seizures. Researchers standardized it with caregivers of 123 people with Dravet syndrome, ages 3 to 41, and found excellent test-retest reliability (overall score correlation of about 0.98). When compared against widely used general-purpose scales, such as the Vineland Adaptive Behavior Scales and the Child Behavior Checklist, the D-DAND showed strong correlation with some but notably weaker correlation with others, suggesting it captures Dravet-specific features of cognition, behavior, sleep, and adaptive functioning that generic instruments are not built to detect. In practical terms, this means something many families already sense — that day-to-day struggles with behavior, sleep, and development are a distinct, measurable part of the condition, not just background noise around seizure control.
Rethinking What Counts as Treatment Success
A 2026 Italian expert consensus published in Epilepsy & Behavior, developed by 12 epilepsy specialists, concluded that non-seizure issues, including cognition, behavior, sleep, communication, motor function, and adaptive skills, drive much of the lifelong disability and family burden in Dravet and Lennox-Gastaut syndromes, often independently of how well seizures themselves are controlled. The panel also discussed fenfluramine, an approved anti-seizure medication, noting it may offer additional benefits across some of these non-seizure domains in Dravet syndrome specifically, though the panel was careful to note that evidence in this area remains uneven and that some authors disclosed financial ties to pharmaceutical companies, including fenfluramine's manufacturer. The panel's broader point was that structured monitoring of non-seizure issues, not seizure frequency alone, should guide what counts as meaningful treatment progress.
Moving Toward Whole-Person Care
- Track more than seizure counts. If your care team only measures seizures, consider asking whether tools like the D-DAND scale, or similar structured assessments, could help capture changes in behavior, sleep, and adaptive skills over time.
- Treat new or worsening behavior changes as real symptoms. Developmental and behavioral shifts in Dravet syndrome are a recognized, measurable part of the condition, not something to dismiss as unrelated to the diagnosis.
- Raise SUDEP directly if it hasn't come up. Given how often this conversation is delayed or skipped altogether, it is reasonable and appropriate to bring it up yourself rather than wait for your care team to initiate it.
- Seek out Dravet-specific resources, not just general epilepsy ones. Organizations like Dravet syndrome foundations often maintain registries, caregiver networks, and risk-reduction guidance tailored specifically to this condition's unusual profile.
- Protect your own mental health as part of care, not separate from it. Caregiver anxiety and sleep disruption linked to SUDEP fear are well documented but rarely treated directly — seeking your own support is a legitimate and important part of caring for your child.